FRI study shows the potential of an inhaled P13K delta inhibitor in COPD-exacerbations.
July 9, 2021 3:20 pm Leave your thoughtsA well powered study with FRI as primary endpoint shows the potential of an inhaled P13K delta inhibitor in COPD-exacerbations. A recent paper, published in the Int. Journal of Chronic Obstructive... View Article